Assessing the Risks and Benefits of Step-Down Asthma Care: A Case-Based Approach
Authors:
- 17 February 2015
- journal article
- review article
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 15 (3) , 1-8
Abstract
Guidelines have called for pharmacologic stepped care to improve asthma treatment. Therapeutic options which have been approved provide physicians and their patients alternatives for stepping up asthma treatment to achieve control. However, few studies have been performed to identify and characterize procedures for optimal stepping-down treatment in patients with asthma. The resulting uncertainty as well as a lack of prioritization for asthma reassessment once control has been maintained has led to a lack of well-defined procedures for stepping down asthma treatment. However, recent studies provide guidance regarding the risks of stepping down asthma medications. This review uses case-based examples to demonstrate how health care providers may engage patients in discussions regarding guideline recommendations to promote individualized asthma care.Keywords
This publication has 56 references indexed in Scilit:
- The risk of asthma exacerbation after stopping low-dose inhaled corticosteroids: A systematic review and meta-analysis of randomized controlled trialsJournal of Allergy and Clinical Immunology, 2013
- Severe Asthma: Lessons Learned from the National Heart, Lung, and Blood Institute Severe Asthma Research ProgramAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in childrenJournal of Allergy and Clinical Immunology, 2008
- Randomized Comparison of Strategies for Reducing Treatment in Mild Persistent AsthmaNew England Journal of Medicine, 2007
- Rescue Use of Beclomethasone and Albuterol in a Single Inhaler for Mild AsthmaNew England Journal of Medicine, 2007
- Asthma Treatment in a Population-Based Cohort: Putting Step-Up and Step-Down Treatment Changes in ContextMayo Clinic Proceedings, 2007
- Case-control study of severe life threatening asthma (SLTA) in a developing communityThorax, 2006
- Fluticasone Propionate Results in Improved Glucocorticoid Receptor Binding Affinity and Reduced Oral Glucocorticoid Requirements in Severe AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Chemosensitivity and Perception of Dyspnea in Patients with a History of Near-Fatal AsthmaNew England Journal of Medicine, 1994
- Reduction of budesonide after a year of increased use: A randomized controlled trial to evaluate whether improvements in airway responsiveness and clinical asthma are maintainedJournal of Allergy and Clinical Immunology, 1991